UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025014
Receipt number R000028786
Scientific Title A resarch of Local Anesthesia spreading area and anesthetic area by quadratus lumborm block.
Date of disclosure of the study information 2017/01/15
Last modified on 2017/08/04 23:39:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A resarch of Local Anesthesia spreading area and anesthetic area by quadratus lumborm block.

Acronym

A resarch of Local Anesthesia spreading area and anesthetic area by quadratus lumborm block.

Scientific Title

A resarch of Local Anesthesia spreading area and anesthetic area by quadratus lumborm block.

Scientific Title:Acronym

A resarch of Local Anesthesia spreading area and anesthetic area by quadratus lumborm block.

Region

Japan


Condition

Condition

Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Local anesthesia spreading area

Basic objectives2

Others

Basic objectives -Others

Anesthetic area

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We confirm the expanse of the local anesthetic by MRI.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Quadratus lumborm block with 0.2% ropivacaine 20ml.
After 60 minutes, MRI will be done.
After 90 minutes, anethetized area was checked by cold sign and/or pin prick test.
After more two days, crossover test.
5 persons, and 10 cases will be done.

Interventions/Control_2

the other side, quadratus lumborum block, which the injection point is changed, with 0.2 % ropivacaine 20ml.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

The volunteer that informed consent was provided.

Key exclusion criteria

Anatominal transformation of the chest-lumbar vertebrae
Operation career of the chest lumbar vaertebrae
Operation career of the associated body surface
Caustrophobia
The internal metal not to fit MRI
Within two weeks before at least examination, it is a person with the internal use of NSAIDs
Coaglopathy
Electrocardiogram abnormality
Allergy for the drug to use for this examination
When we judge the participation in this examination to be inappropriate

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takahiro Tamura

Organization

Nagoya University Graduate school of medicine

Division name

Department of Anesthesiology

Zip code


Address

Tsurumai-cho 65, Showa-ku, Nagoya, 466-8560, Japan

TEL

052-741-2111

Email

takahiro@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takahiro Tamura

Organization

Nagoya University Graduate school of medicine

Division name

Department of Anesthesiology

Zip code


Address

Tsurumai-cho 65, Showa-ku, Nagoya, 466-8560, Japan

TEL

052-741-2111

Homepage URL


Email

takahiro@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 11 Month 28 Day

Last modified on

2017 Year 08 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028786


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name